{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:44:18Z","timestamp":1789015458086,"version":"build-2803163510"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.1001\/jamadermatol.2021.2191","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T14:39:59Z","timestamp":1625063999000},"page":"954","source":"Crossref","is-referenced-by-count":20,"title":["T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma"],"prefix":"10.1001","volume":"157","author":[{"given":"Jennifer A.","family":"Marks","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Switchenko","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J.","family":"Martini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Tarabadkar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Winship Cancer Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad K.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Winship Cancer Institute, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Lechowicz","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela B.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi210028r1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"issue":"11","key":"doi210028r2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma.","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi210028r3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/jid.2008.49","article-title":"T-cell clonality assays: how do they compare?","volume":"128","author":"Cozzio","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"7","key":"doi210028r4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/exd.2014.23.issue-7","article-title":"T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.","volume":"23","author":"Humme","year":"2014","journal-title":"Exp Dermatol"},{"key":"doi210028r5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fmed.2019.00181","article-title":"Next-generation sequencing technologies for early-stage cutaneous T-cell lymphoma.","volume":"6","author":"Fujii","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"doi210028r6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with S\u00e9zary syndrome.","volume":"92","author":"Fraser-Andrews","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"doi210028r7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/sj.jid.5701109","article-title":"TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.","volume":"128","author":"Ponti","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"440","key":"doi210028r8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5894","article-title":"High-throughput sequencing of the T cell receptor \u00df gene identifies aggressive early-stage mycosis fungoides.","volume":"10","author":"de Masson","year":"2018","journal-title":"Sci Transl Med"},{"issue":"13","key":"doi210028r9","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"issue":"5","key":"doi210028r10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u00df chain restriction.","volume":"74","author":"Gibson","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210028r11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/bjd.2005.153.issue-1","article-title":"Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and S\u00e9zary syndrome.","volume":"153","author":"Klemke","year":"2005","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi210028r12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaad.2014.10.019","article-title":"Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and S\u00e9zary syndrome in the southeastern United States: a single-institution cohort.","volume":"72","author":"Desai","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi210028r13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"8","key":"doi210028r14","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/cancers12082311","article-title":"Time to next treatment as a meaningful endpoint for trials of primary cutaneous lymphoma.","volume":"12","author":"Campbell","year":"2020","journal-title":"Cancers (Basel)"},{"key":"doi210028r15","journal-title":"Leukemia"},{"issue":"5","key":"doi210028r17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.6004\/jnccn.2020.0022","article-title":"NCCN Guidelines insights: primary cutaneous lymphomas, version 2.2020.","volume":"18","author":"Mehta-Shah","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"doi210028r18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.01.076","article-title":"Blood classification and blood response criteria in mycosis fungoides and S\u00e9zary syndrome using flow cytometry: recommendations from the EORTC Cutaneous Lymphoma Task Force.","volume":"93","author":"Scarisbrick","year":"2018","journal-title":"Eur J Cancer"},{"issue":"31","key":"doi210028r19","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal.","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"doi210028r20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1182\/blood-2004-06-2220","article-title":"Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications.","volume":"105","author":"Assaf","year":"2005","journal-title":"Blood"},{"issue":"6","key":"doi210028r21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1309\/AJCP09OTJOYAVZZK","article-title":"Simplified flow cytometric assessment in mycosis fungoides and S\u00e9zary syndrome.","volume":"136","author":"Hristov","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"doi210028r22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/AJCP1NA3YCHCDEIG","article-title":"Blood flow cytometry in S\u00e9zary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.","volume":"143","author":"Novelli","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"3, pt 1","key":"doi210028r23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0190-9622(96)90605-2","article-title":"Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.","volume":"35","author":"Harmon","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi210028r24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jclinpath-2013-201748","article-title":"Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma: implications for staging and prognosis.","volume":"67","author":"Horna","year":"2014","journal-title":"J Clin Pathol"},{"issue":"1","key":"doi210028r25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6890-2-5","article-title":"A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy.","volume":"2","author":"Washington","year":"2002","journal-title":"BMC Clin Pathol"},{"issue":"9","key":"doi210028r26","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1182\/blood.V96.9.2987","article-title":"Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.","volume":"96","author":"Delfau-Larue","year":"2000","journal-title":"Blood"},{"issue":"2","key":"doi210028r27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/modpathol.2009.175","article-title":"Flow cytometric detection of peripheral blood involvement by mycosis fungoides and S\u00e9zary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.","volume":"23","author":"Feng","year":"2010","journal-title":"Mod Pathol"},{"issue":"2","key":"doi210028r28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaad.2015.04.030","article-title":"T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.","volume":"73","author":"Sufficool","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi210028r29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.","volume":"122","author":"Poszepczynska-Guign\u00e9","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi210028r30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/bjd.v182.6","article-title":"Revisiting the initial diagnosis and blood staging of mycosis fungoides and S\u00e9zary syndrome with the KIR3DL2 marker.","volume":"182","author":"Roelens","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi210028r31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM197501022920101","article-title":"Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin\u2019s disease.","volume":"292","author":"Lukes","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"doi210028r32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/exd.2017.26.issue-8","article-title":"The biomarker landscape in mycosis fungoides and S\u00e9zary syndrome.","volume":"26","author":"Dulmage","year":"2017","journal-title":"Exp Dermatol"},{"key":"doi210028r16","unstructured":"GitHub. gher-ulg\/DIVAnd.jl. Accessed May 21. 2021. https:\/\/github.com\/gher-ulg\/DIVAnd.jl"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2781377\/jamadermatology_marks_2021_oi_210028_1628612389.03717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T11:19:51Z","timestamp":1629285591000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2781377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.2191","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}